Cargando…
In Vitro Study of the Enzymatic and Nonenzymatic Conjugation of Treosulfan with Glutathione
BACKGROUND AND OBJECTIVES: Treosulfan (dihydroxybusulfan), licensed for the treatment of ovarian carcinoma, is investigated in clinical trials as a myeloablative agent for conditioning prior to hematopoietic stem cell transplantation. Clinical experience shows that treosulfan exhibits lower organ to...
Autores principales: | Romański, Michał, Główka, Franciszek K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746681/ https://www.ncbi.nlm.nih.gov/pubmed/30993552 http://dx.doi.org/10.1007/s13318-019-00555-x |
Ejemplares similares
-
In Vivo Red Blood Cells/Plasma Partition Coefficient of Treosulfan and Its Active Monoepoxide in Rats
por: Romański, Michał, et al.
Publicado: (2018) -
Treosulfan Pharmacokinetics and its Variability in Pediatric and Adult Patients Undergoing Conditioning Prior to Hematopoietic Stem Cell Transplantation: Current State of the Art, In-Depth Analysis, and Perspectives
por: Romański, Michał, et al.
Publicado: (2018) -
Population pharmacokinetic approach for evaluation of treosulfan and its active monoepoxide disposition in plasma and brain on the basis of a rat model
por: Danielak, Dorota, et al.
Publicado: (2020) -
Correction to: Population pharmacokinetic approach for evaluation of treosulfan and its active monoepoxide disposition in plasma and brain on the basis of a rat model
por: Danielak, Dorota, et al.
Publicado: (2020) -
Population pharmacokinetics of treosulfan and development of a limited sampling strategy in children prior to hematopoietic stem cell transplantation
por: Danielak, Dorota, et al.
Publicado: (2017)